You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Cholinesterase Inhibitors as Adjunctive Therapy in Patients with Schizophrenia and Schizoaffective Disorder
|
---|---|
Published in |
CNS Drugs, August 2012
|
DOI | 10.2165/11530260-000000000-00000 |
Pubmed ID | |
Authors |
Salma R. I. Ribeiz, Débora P. Bassitt, Jony A. Arrais, Renata Avila, David C. Steffens, Cássio M. C. Bottino |
Abstract |
Cognitive deficits have been described in patients with schizophrenia from the first descriptions of dementia praecox to current concepts of cognitive dysmetria. Nevertheless, little is known about how to deal with them. In Alzheimer disease, cholinergic deficit is found and cholinesterase inhibitors have been used to delay the progression of memory and cognitive dysfunction. Several lines of evidence suggest that the cholinergic system may be disrupted in schizophrenia. |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | <1% |
Sweden | 1 | <1% |
United Kingdom | 1 | <1% |
Spain | 1 | <1% |
United States | 1 | <1% |
Unknown | 96 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 16 | 16% |
Researcher | 15 | 15% |
Student > Postgraduate | 14 | 14% |
Student > Master | 13 | 13% |
Student > Doctoral Student | 6 | 6% |
Other | 15 | 15% |
Unknown | 22 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 31% |
Psychology | 23 | 23% |
Neuroscience | 6 | 6% |
Agricultural and Biological Sciences | 3 | 3% |
Nursing and Health Professions | 3 | 3% |
Other | 9 | 9% |
Unknown | 26 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2024.
All research outputs
#5,446,629
of 25,374,647 outputs
Outputs from CNS Drugs
#512
of 1,388 outputs
Outputs of similar age
#38,820
of 187,950 outputs
Outputs of similar age from CNS Drugs
#164
of 541 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,388 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.6. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,950 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 541 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.